Last quarter (Q4 2023), Vera Therapeutics's total revenue was $482.00K, a decrease of 0.00% from the same quarter last year. In Q4, Vera Therapeutics's net income was $-25.80M. See Vera Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 1.93M	$ 1.93M	$ 1.93M	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 1.93M	$ 1.93M	$ 1.93M	-	-	-
Operating Expense	$ 102.01M	$ 102.01M	$ 90.90M	$ 34.40M	$ 49.24M	$ 11.70M
Operating Income	$ -102.01M	$ -102.01M	$ -90.90M	$ -34.40M	$ -49.24M	$ -11.70M
Net Non Operating Interest Income Expense	$ 4.19M	$ 4.19M	$ 758.00K	$ -5.00K	$ -95.00K	$ 108.00K
Other Income Expense	$ -2.08M	$ -2.08M	$ -866.00K	$ -1.80M	$ -4.07M	$ -261.00K
Pretax Income	$ -95.99M	$ -95.99M	$ -89.06M	$ -32.61M	$ -53.41M	$ -11.85M
Tax Provision	$ 1.00K	$ 1.00K	$ 1.00K	$ 1.00K	$ 1.00K	$ 1.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -95.85M	$ -95.99M	$ -89.28M	$ -32.61M	$ -53.41M	$ -11.85M
Basic EPS	$ -2.29	$ -2.25	$ -3.35	$ -2.43	$ -13.10	$ -2.91
Diluted EPS	$ -2.29	$ -2.25	$ -3.35	$ -2.43	$ -13.10	$ -2.91
Basic Average Shares	$ 170.83M	$ 42.71M	$ 26.57M	$ 13.44M	$ 4.08M	$ 4.08M
Diluted Average Shares	$ 170.83M	$ 42.71M	$ 26.57M	$ 13.44M	$ 4.08M	$ 4.08M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 102.01M	$ 102.01M	$ 90.90M	$ 34.40M	$ 49.24M	$ 11.70M
Net Income From Continuing And Discontinued Operation	$ -95.99M	$ -95.99M	$ -89.06M	$ -32.61M	$ -53.41M	$ -11.85M
Normalized Income	$ -49.55M	$ -75.83M	$ -73.05M	-	$ -51.23M	$ -11.66M
Interest Expense	-	-	-	-	$ 166.00K	$ 51.00K
EBIT	$ -92.20M	$ -92.20M	$ -88.06M	$ -32.60M	$ -53.25M	$ -11.80M
EBITDA	$ -71.43M	$ -89.98M	$ -85.79M	$ -32.60M	$ -52.99M	$ -11.29M

Currency in USD

Vera Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing